BackDermapharm Holding SE Overview

Dermapharm Holding SE Other Current Liabilities

Latest other current liabilities for DMPHF: $160M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$157.35M
↑ 29.58% YoYΔ $35.92M vs prior year quarter

Peer trimmed avg / median

Loading

Dermapharm Holding SE Other Current Liabilities History

Loading

Dermapharm Holding SE vs. peers: Other Current Liabilities Comparison

Loading

Dermapharm Holding SE Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Dermapharm Holding SE (DMPHF) FAQ

As of the most recent data (September 2026), DMPHF shows a other current liabilities of $160M. That compares with $120M in the prior-year period — up 29.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMPHF's other current liabilities is now $160M (was $120M) — a 29.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Dermapharm Holding SE is outperforming or lagging.

Tracking DMPHF's other current liabilities over time shows whether Dermapharm Holding SE is scaling, shrinking, or reshaping that part of the business. The current reading is $160M That compares with $120M in the prior-year period — up 29.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Dermapharm Holding SE's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $160M) with ownership activity and broader fundamentals.